Description

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. According to a report by StrategyHelix, the global acne treatment market is set to increase by US$ 2,242.4 million during 2022-2028, growing at a CAGR of 5.1% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for acne treatment. The global acne treatment market is segmented on the basis of treatment, acne type, end user, and region. On the basis of treatment, the global acne treatment market has been segmented into medication, therapeutic devices. The medication segment is estimated to account for the largest share of the global acne treatment market. By acne type, the global acne treatment market has been segmented into moderate, mild, moderate to severe. Based on end user, the global acne treatment market is categorized into hospitals & clinics, specialty centers. Geographically, the global acne treatment market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The medication market is further segmented into retinoids, antibiotics, hormonal agents, and others. Furthermore, the medication by drug type market has been categorized into OTC, and prescription. The medication by route of administration market is further divided into topical, oral, and injectable. The therapeutic devices market is further segmented into laser treatment, and microdermabrasion.

The global acne treatment market is highly competitive. Key companies profiled in the report include Allergan plc, Almirall S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the acne treatment market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Treatment: medication, therapeutic devices
Acne type: moderate, mild, moderate to severe
End user: hospitals & clinics, specialty centers
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global acne treatment market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Acne treatment market overview
Part 3. Market breakdown by treatment
– Medication
– Therapeutic devices
Part 4. Market breakdown by acne type
– Moderate
– Mild
– Moderate to severe
Part 5. Market breakdown by end user
– Hospitals & clinics
– Specialty centers
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Allergan plc
– Almirall, S.A.
– Bausch Health Companies Inc.
– F. Hoffmann-la Roche Ltd.
– Galderma S.A. (Nestle S.A.)
– GlaxoSmithKline Plc (GSK)
– Johnson & Johnson
– Mylan N.V.
– Perrigo Company plc
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer